Trulicity vs. Tanzeum

• Are Trulicity and Tanzeum the Same Thing?
• What Are Possible Side Effects of Trulicity?
• What Are Possible Side Effects of Tanzeum?
• What Is Trulicity?
• What Is Tanzeum?
• What Drugs Interact with Trulicity?
• What Drugs Interact with Tanzeum?
• How Should Trulicity Be Taken?
• How Should Tanzeum Be Taken?

Trulicity (dulaglutide) and Tanzeum (albiglutide) are human GLP-1 receptor agonists used as adjuncts to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Side effects of Trulicity and Tanzeum that are similar include nausea, vomiting, indigestion/heartburn, and diarrhea.

Side effects of Trulicity that are different from Tanzeum include abdominal pain or discomfort, decreased appetite, frequent bowel movements, fatigue, constipation, gas, bloating, gastroesophageal reflux disease (GERD), weakness/lack of energy, feeling unwell (malaise), belching, and low blood sugar (hypoglycemia).

Side effects of Tanzeum that are different from Trulicity include injection site reactions (such as itching, rash, redness, bleeding, itching), cough, back pain, joint pain, sinus infection (sinusitis), upper respiratory tract infections, and cold or flu symptoms.

Both Trulicity and Tanzeum may interact with other oral medications taken at the same time.

Common side effects of Trulicity include:

• nausea,
• diarrhea,
• frequent bowel movements,
• vomiting,
• abdominal pain or discomfort,
• decreased appetite,
• indigestion,
• fatigue,
• constipation,
• gas,
• bloating,
• gastroesophageal reflux disease (GERD),
• weakness/lack of energy,
• feeling unwell (malaise),
• belching, and
• low blood sugar (hypoglycemia).

Common side effects of Tanzeum include:

• diarrhea,
• nausea,
• injection site reactions (such as itching, rash, redness, bleeding, itching),
• cough,
• back pain,
• joint pain,
• diarrhea,
• sinus infection (sinusitis),
• upper respiratory tract infections,
• vomiting,
• indigestion/heartburn, and
• cold or flu symptoms.

Trulicity (dulaglutide) is a human GLP-1 receptor agonist used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Tanzeum (albiglutide) Pen for Injection for Subcutaneous Use is a GLP-1 receptor agonist, a recombinant fusion protein used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Trulicity may interact with other oral medications. Tell your doctor all medications and supplements you use. During pregnancy, Trulicity should be taken only if prescribed; it is unknown if it would affect a fetus. It is unknown if Trulicity passes into breast milk. Consult your doctor before breastfeeding.

Tanzeum may affect the absorption of medications taken orally at the same time. It may interact with other drugs. Tell your doctor all medications and supplements you use. Tanzeum is generally not recommended for use during pregnancy. Due to the long washout period for Tanzeum, patients should consider stopping the drug at least 1 month before a planned pregnancy. It is unknown if this drug passes into breast milk but it may be possible and could result in decreased body weight of nursing infants. Consult your doctor before breastfeeding.

The recommended initiating dose of Trulicity is 0.75 mg once weekly. The maximum recommended dose is 1.5 mg once weekly.

The recommended dosage of Tanzeum is 30 mg once weekly given as a subcutaneous injection in the abdomen, thigh, or upper arm region. The dosage may be increased to 50 mg once weekly if the glycemic response is inadequate.